Exome Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-159,552	Closed	-$2.01M	–	68
2024 Q4	$2.01M	Buy	+159,552	New	+$2.01M	1.51%	29
2024 Q1	–	Sell	-91,800	Closed	-$2.75M	–	69
2023 Q4	$2.75M	Buy	+91,800	New	+$2.75M	2.72%	14